BONH
COLL icon

Bank of New Hampshire’s Collegium Pharmaceutical COLL Stock Holding History

Bank of New Hampshire’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-140
Closed -$4.63K – 542
2026
Q1 		$4.63K Buy
+140
New +$5.93K ﹤0.01% 496

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Bank of New Hampshire's COLL Position: Q2 2026 in Review

Bank of New Hampshire sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 140 shares — an estimated $4.63K sold.

Bank of New Hampshire first reported a position in COLL in Q1 2026 and held it in 1 quarter. The position peaked at $4.63K in Q1 2026. 105 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Bank of New Hampshire reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Bank of New Hampshire sold 140 Collegium Pharmaceutical shares in Q2 2026, an estimated $4.63K.
  • Bank of New Hampshire first reported a position in Collegium Pharmaceutical in Q1 2026 and held it in 1 quarter.
  • Bank of New Hampshire's Collegium Pharmaceutical position peaked at $4.63K in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.